Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_assertion type Assertion NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_head.
- NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_assertion description "[To compare the expression of two promising circulating micro-ribonucleic acids (miRNAs 21 and 221) in patients with prostate cancer to subjects without cancer and to evaluate their potential role as specific noninvasive molecular biomarkers for prostate cancer diagnosis, circulating miRNAs 21 and 221 expression profiles were analyzed in 20 men aged 50-75�years, presenting with lower urinary tract symptoms (LUTSs) and undergoing transrectal ultrasound (TRUS)-guided prostate biopsy based on either elevated serum prostate-specific antigen (PSA) (>4.0�ng/ml) or suspicious digital rectal examination (DRE).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_provenance.
- NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_assertion evidence source_evidence_literature NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_provenance.
- NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_assertion SIO_000772 25190021 NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_provenance.
- NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_assertion wasDerivedFrom befree-2016 NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_provenance.
- NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_assertion wasGeneratedBy ECO_0000203 NP1217121.RAu2HjqWf21lCRCjr7SDs9Fsf8btIEEFMGz9MnhWeuYfs130_provenance.